title: Myc target miRs and liver cancer: small molecules to get Myc sick.
authors.affiliation: INSERM Unit U785 Pathogenesis and Treatment of Fulminant Hepatitis and Primary Liver Cancer, Hepato-Biliary Center, Paul Brousse Hospital, Villejuif, France.
authors.forename: Marie-Annick
authors.initials: MA
authors.lastname: Buendia
authors.forename: Ludovic
authors.initials: L
authors.lastname: Bourre
authors.forename: Stefano
authors.initials: S
authors.lastname: Cairo
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D015972:Gene Expression Regulation, Neoplastic; D016259:Genes, myc / Q000502:physiology*; D015316:Genetic Therapy; D018197:Hepatoblastoma / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D035683:MicroRNAs / Q000378:metabolism* / Q000627:therapeutic use; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C489427:MYC protein, human; D035683:MicroRNAs; D016271:Proto-Oncogene Proteins c-myc